Table 10.
Antidiabetic activity and lipid metabolism regulation effects of components from A. pilosa.
| A. pilosa extract | Experimental model | Test dose range | Contrast | Route of administration | Pharmacological action | Mechanism of action | References |
|---|---|---|---|---|---|---|---|
| Apigenin 7-O-β-D-glucuronide | NS | IC50 = 7.14 ± 1.75 μM | Ursolic acid (IC50 = 9.43 ± 0.14 μM) | NS | Improve insulin resistance | PTP1B inhibition | [29] |
| Ellagic acid | NS | IC50 = 7.73 ± 0.24 μM | Ursolic acid (IC50 = 9.43 ± 0.14 μM) | NS | Improve insulin resistance | PTP1B inhibition | [29] |
| Quercetin | NS | IC50 = 28.7 ± 1.2 μM | Acarbose (IC50 = 45.2 ± 1.2 μM) | NS | Glycogen decomposition and glucose regulation | Competitively α-glucosidase inhibition | [30] |
| Agrimonolide | NS | IC50 = 24.2 μM | Acarbose (IC50 = 45.2 ± 1.2 μM) | NS | Glycogen decomposition and glucose regulation | Noncompetitively α-glucosidase inhibition | [30] |
| Desmethylagrimonolide | NS | IC50 = 37.4 μM | Acarbose (IC50 = 45.2 ± 1.2 μM) | NS | Improve insulin resistance of HepG2 cells | Non-competitively α-glucosidase inhibition | [30] |
| Agrimonolide | Insulin-resistance HepG2 cells | IC50 = 8.3 ± 0.6 μM | Metformin (IC50 = 18.6 ± 0.8 μM) | NS | Improve insulin resistance of HepG2 cells | Phosphoenolpyruvate carboxykinase inhibition | [68] |
| Agrimonolide | Insulin-resistance HepG2 cells | IC50 = 11.6 ± 0.8 μM | Metformin (IC50 = 12.4 ± 1.6 μM) | NS | Improve insulin resistance of HepG2 cells | Hepatic glucose-6-phosphatase inhibition | [68] |
| Total triterpenoids of Agrimonia pilosa Ledeb (415.97 ± 5.15 mg/g) | 3T3-L1 cells | 1, 5, 25, and 125 μg/ml | Pioglitazone (10 μM) | NS | Insulin sensitization effects with low lipid formation effects | PPARγ↑SREBP-1↑C/EBPα↑, thus upregulating adiponectin and GLUT4 mRNA expression | [69] |
| Total triterpenoids of Agrimonia pilosa Ledeb (the content is not clear) | High sugar concentration-induced IR-HepG2 cells | 5, 25, 50, 15, 100, 125 μg/ml | Rosig (30 μM) | NS | Regulation of lipid metabolism | Improving oxidative stress and regulating the JNK and IRS pathways, thus improved glucose metabolism in IR-HepG2 cells | [41] |
| Agrimol B | 3T3-L1 cells | 3, 10 μg/ml IC50 = 3.35 ± 0.32 μM | Resveratrol (50 μM) and berberine (10 μM) | NS | Regulation of lipid metabolism | PPAR↓、C/EBPα↓、FAS↓、UCP-1 and apoE↓, thus inhibited 3T3-L1 adipocyte differentiation | [70] |